BIVIX (BIVIX) Stock Price & Analysis
BIVIX (BIVIX) rose 5.94% to USD 17.83 as of July 26, 2026 at 03:44 UTC, according to Nexqual real-time market data.
BIVIX last closed at USD 16.83; the session ranged USD 17.83–17.83 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 13.8–18.89 (NAS). Source: Nexqual, July 26, 2026 at 03:44 UTC.
Key Statistics (as of July 26, 2026 at 03:44 UTC)
| Price | USD 17.83 |
|---|---|
| Change | ▲ 5.94% (up) |
| Previous Close | USD 16.83 |
| Open | USD 17.83 |
| Day Range | USD 17.83 – 17.83 |
| 52-Week Range | USD 13.8 – 18.89 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (BIVIX)
Nexqual's technical model rates BIVIX "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 26, 2026 at 03:44 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.04 (neutral) |
| vs SMA50 | Above (USD 15.87) |
| MACD | 0.54 (positive) |
Financial Health Score (BIVIX)
Nexqual rates BIVIX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 03:44 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIVSX | Invenomic Fund Super Institutio | USD 18.11 | ▲ 4.08% |
| BIVRX | Invenomic Fund Investor Class | USD 17.45 | ▲ 4.05% |
| QLEIX | AQR Long-Short Equity Fund Clas | USD 21.04 | ▼ 0.71% |
| HMEZX | Nexpoint Merger Abritrage Fund | USD 19.9 | ▲ 0% |
| MBXIX | Catalyst/Millburn Hedge Strateg | USD 46.56 | ▲ 0.06% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 03:44 UTC. This page is informational and not investment advice.